Darzalex (Daratumumab) is a targeted biologic therapy used in the treatment of Multiple Myeloma. It works by specifically targeting cancer cells and helping the immune system recognize and destroy them.
What is Darzalex (Daratumumab)?
Darzalex is a monoclonal antibody that targets the CD38 protein, which is highly expressed on the surface of multiple myeloma cells.
By binding to these cancer cells, it helps to:
- Destroy malignant plasma cells
- Support the immune system in identifying abnormal cells
- Improve disease control
In simple terms:
It is a targeted therapy that helps the immune system attack myeloma cells.
Indications
Darzalex (Daratumumab) is used in:
- Multiple Myeloma
- Newly diagnosed or relapsed cases, depending on treatment protocols
- Often in combination with other anti-myeloma therapies
Dosage and Administration
- Dose: 1800 mg according to the treatment protocol
- Administered as a subcutaneous injection or intravenous infusion, depending on the formulation
- Given under specialist medical supervision
- Treatment schedule varies according to the prescribed regimen
Common Side Effects
May include:
- Fatigue
- Cold-like symptoms
- Nausea
- Low blood cell counts
- Mild infections
- Infusion- or injection-related reactions
Monitoring During Treatment
Patients on Darzalex (Daratumumab) require:
- Regular complete blood count (CBC) monitoring
- Assessment of treatment response
- Monitoring for signs of infection
- Evaluation of overall health status
Availability & How to Access Treatment
Darzalex (Daratumumab) is available through Macrocare’s approved partners.
You can now request and access the medication easily through us.
WhatsApp contact for medication requests:
Click here
Darzalex (Daratumumab) Darzalex (Daratumumab) 1800 mg is a targeted biologic therapy for Multiple Myeloma that works by targeting CD38-positive cancer cells and improving disease control.
Medical Disclaimer:
This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.